Search results for "ALPHA"

showing 10 items of 3228 documents

Enhancing effects of acute psychosocial stress on priming of non-declarative memory in healthy young adults.

2011

Social stress affects cognitive processes in general, and memory performance in particular. However, the direction of these effects has not been clearly established, as it depends on several factors. Our aim was to determine the impact of the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic nervous system (SNS) reactivity to psychosocial stress on short-term non-declarative memory and declarative memory performance. Fifty-two young participants (18 men, 34 women) were subjected to the Trier Social Stress Task (TSST) and a control condition in a crossover design. Implicit memory was assessed by a priming test, and explicit memory was assessed by the Rey Auditory Verbal Learning Test…

AdultMaleendocrine systemSympathetic Nervous SystemAdolescentHydrocortisonePhysiologyEffects of stress on memoryAffect (psychology)Social EnvironmentDevelopmental psychologyBehavioral NeuroscienceYoung AdultMemoryExplicit memoryHumansSalivaSocial stressAnalysis of VarianceSex CharacteristicsCross-Over StudiesEndocrine and Autonomic SystemsCognitionVerbal LearningPsychiatry and Mental healthNeuropsychology and Physiological PsychologySocioeconomic FactorsData Interpretation StatisticalMental RecallFemaleImplicit memoryAnalysis of varianceCuesalpha-AmylasesPsychologyPriming (psychology)Psychomotor PerformanceStress PsychologicalClinical psychologyStress (Amsterdam, Netherlands)
researchProduct

Sub-acute effects of interferon-α2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans

1992

Abstract This study investigated the chronic effects of interferon-α2 (IFN-α2) on hormonal secretion in humans. Six patients suffering from chronic hepatitis B or C infection received SC doses of 3 million IU IFN-α2 three times a week for 4 mo. Each patientwas examined for hormone secretion four times: the day before initial IFN-α2 administration (day 0), the day of the first injection (day 1), and 4 wk after start of IFN therapy on days 27 (without IFN administration) and 28 (with IFN administration). Adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (hGH), and prolactin (PRL) were measured in plasma samples drawn at 30-min intervals between 1600h and 2400h. Acute administratio…

AdultMaleendocrine systemmedicine.medical_specialtyHydrocortisonemedicine.drug_classEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAlpha interferonStimulationInterferon alpha-2BiologyPeptide hormoneEndocrinologyAdrenocorticotropic HormoneInternal medicinemedicineHumansBiological PsychiatryAgedHydrocortisoneEndocrine and Autonomic SystemsInterferon-alphaMiddle AgedHepatitis BHepatitis CRecombinant ProteinsProlactinCircadian RhythmProlactinPsychiatry and Mental healthSteroid hormoneEndocrinologyGrowth HormoneFemaleGonadotropinhormones hormone substitutes and hormone antagonistsmedicine.drugHormonePsychoneuroendocrinology
researchProduct

Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.

1997

This study was designed to assess patients with chronic hepatitis C (CHC) for the presence of thyroid autoimmunity and dysfunction, to evaluate the risk of thyroid disorders associated with interferon (IFN) therapy, and to survey the outcome of possible treatment-related thyroid injury. Out of 104 consecutive untreated patients (30 women and 74 men; mean age, 52.7 years), 8 (7.7%) were found seropositive for thyroid autoantibodies (ThyAb), whereas seropositivity in healthy controls was 1/98 (1.3%). The relative increase in risk of developing thyroid autoimmunity associated with CHC was 760% (95% Cl, 220–1300%). No patients had abnormalities of thyroid function tests, but on IFN treatment, 3…

AdultMaleendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismThyroid GlandThyrotropinInterferon alpha-2Thyroid function testsGastroenterologyIodide PeroxidaseThyroiditisAutoimmune DiseasesAutoimmune thyroiditisEndocrinologyInternal medicinemedicineHumansProspective StudiesAutoantibodiesAutoimmune diseasemedicine.diagnostic_testbusiness.industryThyroidInterferon-alphaMiddle Agedmedicine.diseaseHepatitis CThyroid DiseasesAnti-thyroid autoantibodiesRecombinant ProteinsDiscontinuationThyroxinemedicine.anatomical_structureImmunologyTriiodothyronineFemaleThyroid functionbusiness
researchProduct

Prismatic Adaptation Modulates Oscillatory EEG Correlates of Motor Preparation but Not Visual Attention in Healthy Participants.

2017

Prismatic adaption (PA) has been proposed as a tool to induce neural plasticity and is used to help neglect rehabilitation. It leads to a recalibration of visuomotor coordination during pointing as well as to aftereffects on a number of sensorimotor and attention tasks, but whether these effects originate at a motor or attentional level remains a matter of debate. Our aim was to further characterize PA aftereffects by using an approach that allows distinguishing between effects on attentional and motor processes. We recorded EEG in healthy human participants (9 females and 7 males) while performing a new double step, anticipatory attention/motor preparation paradigm before and after adaptat…

AdultMalegenetic structuresBehavioral/Cognitivebrain oscillationsFunctional LateralityYoung AdultaftereffectsFigural AftereffectOrientationAdaptation PsychologicalHumansAttentionattention orientingEEGResearch Articlesprismatic adaptationElectroencephalographyAnticipation PsychologicalHealthy VolunteersAlpha RhythmSpace PerceptionEvoked Potentials VisualFemaleBeta Rhythmmotor preparationPsychomotor PerformanceThe Journal of neuroscience : the official journal of the Society for Neuroscience
researchProduct

Gesture's body orientation modulates the N400 for visual sentences primed by gestures

2020

Abstract Body orientation of gesture entails social‐communicative intention, and may thus influence how gestures are perceived and comprehended together with auditory speech during face‐to‐face communication. To date, despite the emergence of neuroscientific literature on the role of body orientation on hand action perception, limited studies have directly investigated the role of body orientation in the interaction between gesture and language. To address this research question, we carried out an electroencephalography (EEG) experiment presenting to participants (n = 21) videos of frontal and lateral communicative hand gestures of 5 s (e.g., raising a hand), followed by visually presented …

AdultMalemedia_common.quotation_subjectPrefrontal CortexElectroencephalography050105 experimental psychologyYoung Adult03 medical and health sciences0302 clinical medicinebody orientationKinesicsPerceptionmedicineHumansN4000501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingPrefrontal cortexsemanticsEvoked PotentialsResearch Articlesmedia_commonbeta oscillationsPsycholinguisticsGesturesRadiological and Ultrasound Technologymedicine.diagnostic_testSocial perception05 social sciencessocial perceptionElectroencephalographyN400ComprehensionAlpha RhythmPattern Recognition VisualReadingNeurologygestureFemaleNeurology (clinical)AnatomyBeta RhythmPsychology030217 neurology & neurosurgerySentenceResearch ArticleCognitive psychologyGestureHuman Brain Mapping
researchProduct

Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells

1988

Colony-stimulating factors are required for survival proliferation, differentiation and functional activation of granulocytes, macrophages and their precursor cells. In the present report, however, we demonstrate antiproliferative activity of recombinant human (rh) granulocyte-macrophage colony-stimulating factor (GM-CSF) on monoblast cell line U-937 and provide evidence for the involvement of tumor necrosis factor alpha TNF-alpha and interleukin 1 beta (IL 1 beta) in its growth inhibitory action. GM-CSF (but not granulocyte CSF, G-CSF or macrophage CSF, M-CSF) suppressed DNA synthesis and self renewal of U-937 cells. Similarly, medium conditioned by U-937 cells in response to GM-CSF (GM-CS…

AdultMalemedicine.drug_classImmunologyMonoblastBiologyGranulocyteMonoclonal antibodyMonocytesColony-Stimulating FactorsTumor Cells CulturedmedicineHumansImmunology and AllergyMacrophageTumor Necrosis Factor-alphaMolecular biologyRecombinant ProteinsStimulation ChemicalGranulocyte macrophage colony-stimulating factormedicine.anatomical_structureCell culturebiology.proteinTumor necrosis factor alphaLymphoma Large B-Cell DiffuseAntibodyCell DivisionInterleukin-1medicine.drugEuropean Journal of Immunology
researchProduct

Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS).

2019

Fabry's disease (FD) is an X-linked lysosomal storage disorder caused by the deficient activity of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) leading to intracellular accumulation of globotriaosylceramide (Gb3). Patients with amenable mutations can be treated with migalastat, a recently approved oral pharmacologic chaperone to increase endogenous alpha-Gal A activity. We assessed safety along with cardiovascular, renal, and patient-reported outcomes and disease biomarkers in a prospective observational multicenter study after 12 months of migalastat treatment under real-world conditions. Fifty-nine (28 females) patients (34 (57.6%) pretreated with enzyme replacement therapy) w…

AdultMalemedicine.medical_specialty1-DeoxynojirimycinTime FactorsGlobotriaosylceramideRenal function030226 pharmacology & pharmacyGastroenterologyVentricular Function Left03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineMigalastatGermanymedicineClinical endpointHumansPharmacology (medical)Genetic Predisposition to DiseaseProspective StudiesPharmacologySphingolipidsVentricular Remodelingbusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry's diseaseFabry diseaseBlood pressureTreatment Outcomechemistry030220 oncology & carcinogenesisalpha-GalactosidaseMutationFabry DiseaseFemaleGlycolipidsbusinessBiomarkersGlomerular Filtration RateClinical pharmacology and therapeutics
researchProduct

Hearing loss in Fabry disease: data from the Fabry Outcome Survey

2006

Hearing loss is a common symptom in Fabry disease, but neither its natural course nor its aetiology has been defined precisely. The aim of this study was to provide a detailed epidemiological description of hearing impairment in patients in the Fabry Outcome Survey (FOS), which is the largest available database of Fabry patients. Questionnaires were completed by 566 Fabry patients, of whom 316 reported ear-related symptoms. Pure-tone audiograms from 86 patients, performed before starting enzyme replacement therapy, were analysed and compared with age- and sex-specific normal values (International Organization for Standardization, ISO 7029). When compared to an age-matched population (ISO 70…

AdultMalemedicine.medical_specialty1303 BiochemistryAdolescentHearing lossHearing Loss SensorineuralHearing Loss ConductiveClinical BiochemistryPopulationPresbycusis610 Medicine & health10045 Clinic for OtorhinolaryngologyAudiology1308 Clinical BiochemistryBiochemistrySex Factorsotorhinolaryngologic diseasesmedicineHumansChildHearing LosseducationAgededucation.field_of_studymedicine.diagnostic_testbusiness.industryIncidenceGeneral MedicineAudiogramEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseSurgeryConductive hearing lossEuropeChild PreschoolHealth Care SurveysSensory Thresholdsalpha-GalactosidaseAudiometry Pure-ToneFabry DiseaseFemaleAudiometrymedicine.symptombusiness
researchProduct

Perihepatic lymph nodes and antiviral response in chronic HCV-associated hepatitis.

2003

To identify predictive factors of response to interferon alpha (IFN-alpha) plus ribavirin therapy in patients with chronic hepatitis C (CHC), the presence of lymphadenopathy (LyA) of the hepatoduodenal ligament and other variables were investigated. A total of 110 patients with histologically proven CHC were enrolled in this study. Ultrasound (US) was performed at the start and end of therapy and 6 months after stopping therapy. At baseline, LyA was present in 35 (43.7%) of 80 patients with alanine aminotransferase (ALT) values and grading was significantly higher than in the LyA-negative group. LyA was more frequent in nonresponders (nonR) than in relapsers (relR) or sustained responders (…

AdultMalemedicine.medical_specialtyAcoustics and UltrasonicsEnd of therapyBiophysicsAlpha interferonGastroenterologyAntiviral Agentschemistry.chemical_compoundInternal medicineRibavirinmedicineHumansUltrasound Lymphadenopathy Chronic hepatitis C Treatment Predictive factors.Radiology Nuclear Medicine and imagingProspective StudiesAlanine aminotransferaseLymph nodeLymphatic DiseasesUltrasonographyHepatitisRadiological and Ultrasound Technologybusiness.industryRibavirinInterferon-alphaHepatoduodenal ligamentHepatitis C ChronicMiddle Agedmedicine.diseasePrognosisSurgerymedicine.anatomical_structureLogistic ModelsTreatment OutcomechemistryDrug Therapy CombinationFemaleLymphbusinessUltrasound in medicinebiology
researchProduct

Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia.

2011

The World Health Organization Disability Assessment Schedule II (WHODAS II) was developed for assessing disability. This study provides data on the validity and utility of the Spanish version of the WHODAS II in a large sample of patients with schizophrenia.The sample included 352 patients with a schizophrenia spectrum disorder. They completed a comprehensive assessment battery including measures of psychopathology, functionality and quality-of-life. A sub-sample of 36 patients was retested after six months to assess its temporal stability.Participation in society (6.3%) and Life activities (4.0%) were the domains with the highest percentage of missing data. The internal consistency (Cronba…

AdultMalemedicine.medical_specialtyActivities of daily livingAdolescentPsychometricsIntraclass correlationWorld Health OrganizationSeverity of Illness IndexQuality of life (healthcare)Cronbach's alphaActivities of Daily LivingmedicineHumansDisabled PersonsPsychiatryBiological PsychiatryReproducibility of ResultsMiddle AgedMissing datamedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaScale (social sciences)Quality of LifeSchizophreniaFemalePsychologyClinical psychologyPsychopathologySchizophrenia research
researchProduct